Notices and Announcements

The Methodology of CES HK Biotechnology Index Will Be Amended

In order to improve the constituent selection method, today China Securities Index Company Limited and China Exchanges Services Company Limited (CESC) decided to amend the methodology of CES HK Biotechnology Index. The details are as following:

(1) As of the Periodic Review time, eligible securities should have been listed for at last three months; (2) Additional liquidity screening criteria is set; (3) Index constituent number limit is set, the top 30 eligible securities ranked by daily average total market capitalization in the most recent year are chosen for inclusion in the index. If the number of remaining eligible securities is less than 30, all eligible securities will be included; (4) If any constituent security is multi-listed, the calculation of its weight factor will base on the investable shares, which are currently listed and traded on the SEHK; (5) The fast entry rule will be cancelled.

The change in index methodology will be implemented in the next periodic index review.


MethodologyCES HK Biotechnology Index


For further information, please contact:

China Exchanges Services Company Limited

Email: cescinfo@cesc.com

Website: www.cesc.com

 

China Securities Index Company Limited

Email: csindex@sse.com.cn

Website: www.csindex.com.cn

 

China Securities Index Co., Ltd

Sep. 19, 2019


Feedback